1. Home
  2. GOSS vs ZVIA Comparison

GOSS vs ZVIA Comparison

Compare GOSS & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.34

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.18

Market Cap

96.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
ZVIA
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
96.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
GOSS
ZVIA
Price
$0.34
$1.18
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$4.19
$4.93
AVG Volume (30 Days)
10.5M
513.9K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.88
EPS
N/A
N/A
Revenue
$48,471,000.00
$161,259,000.00
Revenue This Year
N/A
$8.33
Revenue Next Year
$144.43
$6.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.01
52 Week Low
$0.32
$1.11
52 Week High
$3.87
$3.66

Technical Indicators

Market Signals
Indicator
GOSS
ZVIA
Relative Strength Index (RSI) 28.06 36.70
Support Level $0.33 $1.12
Resistance Level $0.60 $2.76
Average True Range (ATR) 0.04 0.07
MACD 0.05 0.01
Stochastic Oscillator 13.87 28.12

Price Performance

Historical Comparison
GOSS
ZVIA

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: